This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Novo Nordisk A/s. Active years: 2017-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2020
Title: Innovations by Toke Folke Christensen
Introduction
Toke Folke Christensen is a notable inventor based in Soeborg, Denmark. He has made significant contributions to the field of medical technology, particularly in optimizing drug dosage regimens. With a total of 2 patents, his work focuses on improving patient care through innovative solutions.
Latest Patents
Christensen's latest patents include a system for optimizing a patient's basal insulin dosage regimen over time. This system is designed to determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug. The goal is to maintain the patient's future blood glucose level measurements within a predefined range. Notably, a given blood glucose value is disregarded if no patient-actuated operation indicative of the administration of a dose of an insulin-containing drug has been detected in a predefined amount of time prior to the determination of that blood glucose value.
Career Highlights
Toke Folke Christensen is currently employed at Novo Nordisk A/S, a leading global healthcare company. His work at Novo Nordisk focuses on developing innovative solutions that enhance diabetes management and patient outcomes.
Collaborations
Some of his notable coworkers include Henrik Bengtsson and Louise Wagner Noergaard. Their collaborative efforts contribute to the advancement of medical technologies and patient care.
Conclusion
Toke Folke Christensen's contributions to the field of medical technology through his patents and work at Novo Nordisk highlight his commitment to improving patient care. His innovative systems for optimizing drug dosage regimens are paving the way for better diabetes management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
